Pages that link to "Q41546124"

The following pages link to ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD (Q41546124):

Displaying 14 items.

• Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD. (Q47674664) (← links)
• Verification of a Motion Sensor for Evaluating Physical Activity in COPD Patients. (Q55043726) (← links)
• Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity. (Q55053174) (← links)
• A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD (Q62825758) (← links)
• Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study (Q64056646) (← links)
• AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD (Q64062018) (← links)
• The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects (Q64101434) (← links)
• Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD) (Q90399828) (← links)
• Translation and Cultural Adaptation of PROactive Instruments for COPD in French and Influence of Weather and Pollution on Its Difficulty Score (Q90409587) (← links)
• Characterization of Dyspnea in Veteran Lung Cancer Survivors Following Curative-Intent Therapy (Q90586446) (← links)
• Assessment of physical functioning and handling of tiotropium/olodaterol Respimat® in patients with COPD in a real-world clinical setting (Q91905735) (← links)
• Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base (Q92084486) (← links)
• Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease (Q92156772) (← links)
• The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate (Q93073752) (← links)